PMPRB has released its October 2018 NEWSletter which includes updates on Guideline Reform and PMPRB’s timelines for its Guidelines modernization initiative.
Updates on Guideline Reform
Consultations with stakeholders have progressed more slowly than anticipated, due to conflicting views amongst participants and complexity of reforms.
A January 2019 implementation date for the ... Read More
News & Events
02
Nov2018
23
Oct2018
On November 12-13th, the Market Access Summit will be chaired by PDCI’s Kaitlyn Proulx, Managing Director and John-Paul Dowson, Director, Reimbursement Strategy. We are so excited to see you there that we want to offer you a 20% discount.
That’s not ... Read More
23
Oct2018
Recognizing the increasing demand for PDCI expertise and the growing needs of our clients, we are proud to announce the addition of new staff in our Health Technology Assessment (HTA) and Reimbursement Strategy Teams.
Background
Our vision at PDCI is to be the most trusted and valued pricing and reimbursement strategic partner. ... Read More
01
Oct2018
Did you or your organization submit written comments to the recent national pharmacare consultation? If so, PDCI has volunteered to accumulate & share submissions from all stakeholders on a centrally located webpage available here.
If you would like your voice added to this important policy discussion, please send ... Read More
28
Aug2018
***Participation Requested***
Sharing Responses to the National Pharmacare Public Consultation
Announced in the 2018 federal budget and chaired by former Ontario Health Minister Eric Hoskins, the Advisory Council on the Implementation of National Pharmacare is currently engaging in a national dialogue on how the federal government could implement ... Read More
27
Aug2018
PMPRB published its 2017 annual report this week, recalling an eventful year (complete with proposed amendments to its overarching regulations, poised to fundamentally change its future mandate & operations) and looking forward in 2018 to working constructively with stakeholders to finalize its Guidelines modernization initiative, underway since 2016.
PMPRB 2017 Annual ... Read More
30
Jul2018
PDCI is extremely pleased to announce the promotion of Courtney Abunassar to the position of Associate Director, Market Access and Policy. This promotion is effective immediately.
Courtney joined PDCI in September 2011 as a Junior Pricing and Reimbursement Associate. Since that time Courtney has continued to demonstrate highly strategic approaches to the ... Read More
03
Jul2018
CADTH Publishes New CDR Guidelines & Therapeutic Review Process, providing Framework to Revise CDEC Recommendations
/ CADTH, What's New
Last week, CADTH shared its new Procedure and Submission Guidelines for the CADTH Common Drug Review document which combines the previously separate procedure and submission guidelines into a single document. Manufacturers are encouraged to follow the new guidelines immediately, however new submission requirements will be only be enforced for ... Read More
28
Jun2018
Health Canada, CADTH & INESS Collaborate on Aligned Drug Review Processes
/ CADTH, Health Canada, INESSS
Health Canada, CADTH, and Quebec’s Institut national d’excellence en santé et en services sociaux (INESSS) have officially launched efforts to align regulatory and health technology assessment (HTA) drug reviews for eligible submissions, effective immediately.
Background
The new process stems from Health Canada and HTAs recognizing the need for greater coordination of the ... Read More
14
Jun2018
On June 13, 2018, after considerable time in development, the pCPA released its Brand Process Guidelines for external feedback. The pCPA is interested in receiving feedback from all sectors with a stake in the negotiation process: brand and generic pharmaceutical companies, patient organizations, and other interested parties.
The guidance documents, which ... Read More